AIM: To develop a low-dose controlled-release delivery system for the treatment of periodontal infections. A new sustained release drug system of Poly e-caprolactone (PCL) nanofibers containing doxycycline (DOX) was successfully electrospun and evaluated clinically for periodontal diseases. The retentive doxycycline nanofibres were shown to provide a controlled delivery of the drug. MATERIAL AND METHODS: Nanofibers were prepared with DOX in PCL by electrospinning technique. The drug-coated nanofibres provided sustained effect up to a period of 11 days (264 h) and followed first order release. Forty sites in 7 patients (4 females and 3 males) with chronic periodontitis (5-8mm probing depth) were allocated in 2 experimental treatment groups, Group A-SRP (Scaling and Root Planing) + DOX nanofibers and Group B -SRP (Scaling and Root Planing) alone (control group). All these patients were evaluated clinically for probing depth (PD), plaque index (PI) and gingival index (GI). RESULTS: Both the treatment groups were found to be efficacious in the treatment of periodontal disease as demonstrated by improvement in PD, PI and GI. CONCLUSION: Combination of SRP (Scaling and Root Planing) + DOX nanofibers (Group A) resulted in added benefits compared to the control group.
RCT Entities:
AIM: To develop a low-dose controlled-release delivery system for the treatment of periodontal infections. A new sustained release drug system of Poly e-caprolactone (PCL) nanofibers containing doxycycline (DOX) was successfully electrospun and evaluated clinically for periodontal diseases. The retentive doxycycline nanofibres were shown to provide a controlled delivery of the drug. MATERIAL AND METHODS: Nanofibers were prepared with DOX in PCL by electrospinning technique. The drug-coated nanofibres provided sustained effect up to a period of 11 days (264 h) and followed first order release. Forty sites in 7 patients (4 females and 3 males) with chronic periodontitis (5-8mm probing depth) were allocated in 2 experimental treatment groups, Group A-SRP (Scaling and Root Planing) + DOX nanofibers and Group B -SRP (Scaling and Root Planing) alone (control group). All these patients were evaluated clinically for probing depth (PD), plaque index (PI) and gingival index (GI). RESULTS: Both the treatment groups were found to be efficacious in the treatment of periodontal disease as demonstrated by improvement in PD, PI and GI. CONCLUSION: Combination of SRP (Scaling and Root Planing) + DOX nanofibers (Group A) resulted in added benefits compared to the control group.
Authors: J L Wennström; H N Newman; S R MacNeill; W J Killoy; G S Griffiths; D G Gillam; L Krok; I G Needleman; G Weiss; S Garrett Journal: J Clin Periodontol Date: 2001-08 Impact factor: 8.728
Authors: S Garrett; L Johnson; C H Drisko; D F Adams; C Bandt; B Beiswanger; G Bogle; K Donly; W W Hallmon; E B Hancock; P Hanes; C E Hawley; R Kiger; W Killoy; J T Mellonig; A Polson; F J Raab; M Ryder; N H Stoller; H L Wang; L E Wolinsky; G H Evans; C Q Harrold; R M Arnold; G L Southard Journal: J Periodontol Date: 1999-05 Impact factor: 6.993
Authors: S Garrett; D F Adams; G Bogle; K Donly; C H Drisko; W W Hallmon; E B Hancock; P Hanes; C E Hawley; L Johnson; R Kiger; W Killoy; J T Mellonig; F J Raab; M Ryder; N Stoller; A Polson; H L Wang; L E Wolinsky; R A Yukna; C Q Harrold; M Hill; V B Johnson; G L Soouthard Journal: J Periodontol Date: 2000-01 Impact factor: 6.993
Authors: Geert Verreck; Iksoo Chun; Joel Rosenblatt; Jef Peeters; Alex Van Dijck; Jurgen Mensch; Marc Noppe; Marcus E Brewster Journal: J Control Release Date: 2003-10-30 Impact factor: 9.776
Authors: Agnes B Meireles; Daniella K Corrêa; João Vw da Silveira; Ana Lg Millás; Edison Bittencourt; Gustavo Ea de Brito-Melo; Libardo A González-Torres Journal: Exp Biol Med (Maywood) Date: 2018-05
Authors: Mohamed Y Mahmoud; Sonali Sapare; Keegan C Curry; Donald R Demuth; Jill M Steinbach-Rankins Journal: Front Chem Date: 2020-01-21 Impact factor: 5.221